Eurofins Amatsigroup is a leading international Contract Development and Manufacturing Organization (CDMO), headquartered in France.
Within Eurofins Amatsigroup, we provide high-quality, customized and cost-effective drug development solutions to small biotech and major (bio)pharmaceutical customers.
The company has three strategic pillars:
- Drug substance process development and manufacturing for biologics,
- Pharmaceutical analysis solutions
- Formulation development and manufacturing of sterile and non-sterile clinical or small commercial batches
Clients also benefit from complementary services such as preclinical studies, bioanalysis and clinical trial supply.
Tags
drug productfdaansmtitrationamatsigroupantibioticsdrug substancecdmobiopharmaceuticaldrug developmentbiologicspharmaceuticalmicrobialmicrobiologyizymedfill & finishclinical trial supplyquality controlbioburdenbiotechprocess developmentpharmaceutical analysismanufacturingsterilein-life studiesbioanalysisnon-sterilebpfsouchoth猫que interneefficacit茅 des conservateurscontrole qualited茅veloppement analytiqueiso22716cosmetiquesmicrobiologietestsmethod performance evaluationcontent uniformityanalytical developmentresidue analysisforced degradationanalyticalvalidationdevelopmentparticlessamplescosmeticsdrugsendotoxinssterilityformulation development
We鈥檝e updated our privacy policy so that we are compliant with changing global privacy regulations and to provide you with insight into the limited ways in which we use your data.
You can read the details below. By accepting, you agree to the updated privacy policy.
